K
Kim Schafer
Researcher at University of California, San Diego
Publications - 8
Citations - 976
Kim Schafer is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Viral load & Sleep disorder. The author has an hindex of 6, co-authored 7 publications receiving 928 citations. Previous affiliations of Kim Schafer include University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
Clifford M. Singer,Rochelle E. Tractenberg,Jeffrey Kaye,Kim Schafer,Anthony Gamst,Michael Grundman,Ronald G. Thomas,Leon J. Thal +7 more
TL;DR: Singer et al. as discussed by the authors evaluated the safety and efficacy of 2 dose formulations of melatonin for the treatment of insomnia in patients with Alzheimer's disease and found no statistically significant differences in objective sleep measures.
A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease PHARMACOLOGY
Clifford M. Singer,Rochelle E. Tractenberg,Jeffrey Kaye,Kim Schafer,Anthony Gamst,Michael Grundman,Leon J. Thal +6 more
TL;DR: Based on actigraphy as an objective measure of sleep time, melatonin is not an effective soporific agent in people with Alzheimer's disease.
Journal ArticleDOI
Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers
Toshiyuki Miura,Zabrina L. Brumme,Mark A. Brockman,Pamela C. Rosato,Jennifer Sela,Chanson J. Brumme,Florencia Pereyra,Florencia Pereyra,Daniel Kaufmann,Daniel Kaufmann,Alicja Trocha,Alicja Trocha,Brian L. Block,Brian L. Block,Eric S. Daar,Elizabeth Connick,Heiko Jessen,Anthony D. Kelleher,Eric S. Rosenberg,Eric S. Rosenberg,Martin Markowitz,Kim Schafer,Florin Vaida,Aikichi Iwamoto,Susan J. Little,Bruce D. Walker,Bruce D. Walker,Bruce D. Walker +27 more
TL;DR: Examination of viral replication capacities, HLA types, and virus sequences from 18 HIV-1 controllers identified during primary infection indicates that acute/early stage viruses from persons who become controllers have evidence of reduced replication capacity during the initial stages of infection.
Journal ArticleDOI
Divalproex Sodium in Nursing Home Residents With Possible or Probable Alzheimer Disease Complicated by Agitation A Randomized, Controlled Trial
Pierre N. Tariot,Rema Raman,Laura Jakimovich,Lon S. Schneider,Anton P. Porsteinsson,Ronald G. Thomas,Jacobo Mintzer,Ronald Brenner,Kim Schafer,Leon J. Thal +9 more
TL;DR: This multicenter trial showed no benefit of divalproex sodium for treatment for agitation in dementia at a mean dose of 800 mg/day over 6 weeks, and the results do not support findings from previous trials indicating possible benefit.
Journal ArticleDOI
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection
Martin Markowitz,Florin Vaida,C. Bradley Hare,Daniel Boden,Hiroshi Mohri,Frederick Hecht,Robert C. Kalayjian,Ann Conrad,Donna Mildvan,Judith A. Aberg,Christine Hogan,Christine Hogan,J. Michael Kilby,Henry H. Balfour,Kim Schafer,Douglas D. Richman,Douglas D. Richman,Susan J. Little +17 more
TL;DR: Adjunctive therapy with cyclosporine in this setting of acute and early HIV-1 infection does not provide apparent virologic or immunologic benefit.